CClinicalTrials.gg
Status unknownNCT03812406Updated Jan 23, 2019

Comparison of FAUCS vs. Misgav Ladach

An interventional study of French Abulatory Cesrean Section and Misgav-Ladach in Pain, Postoperative and Ambulation Difficulty, sponsored by Bnai Zion Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-23.

Sponsored by Bnai Zion Medical Center · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2018), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2018, registered Dec 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study aims to compare two techniques for performing a cesarean delivery: Misgav Ladach versus French Ambulatory Cesarean Section (FAUCS). The second techniques has been claimed to reduce post-operative pain, the need for analgesics, and reduce the time for ambulation. Such comparison has not been done so far, and this study will examined if indeed the FAUCS techniques offers any advantages.

Read the detailed description

The FAUCS technique for performing a cesarean section has been described by a French group several years ago, and is claimed to reduce postoperative pain and increase ambulation. With this technique, after making the transverse skin incision, the fascia is opened vertically and to the left of the linea alba. The left rectus abdominis muscle is then pushed laterally, and the abdominal cavity is entered. The uterine incision in performed as usual. Due to the reduced incision size, a special spatula is used to facilitate extraction of the fetal head in some cases. No urinary catheter is used during or after the operation, and fluid administration is restricted during the procedure. The patient is encouraged to get out of bed 3-4 hours post surgery. This technique for performing a cesarean section will be compared with the traditional (Misgav Ladach technique) in terms of post-operative pain, need for analgesics, ambulation, neonatal outcome, and perioperative complications.

02

Conditions studied

  • Pain, Postoperative
  • Ambulation Difficulty

Keywords

  • cesarean
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's planned enrollment of 120 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Bnai Zion Medical Center is the lead sponsor of 102 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients scheduled for a cesarean section
  • term pregnancy: 37-42 weeks
  • singleton pregnancy
  • age 18 and above
  • patients capable of signing an informed consent

Exclusion criteria

Exclusion Criteria:

  • multiple pregnancy
  • emergency cesarean
  • previous 3 cesareans and above
  • placenta accreta
  • uterine myomas in the lower segment
  • fetal growth restriction
  • fetal anemia
  • preeclampsia
  • women scheduled for general anesthesia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    FAUCS

    Patients undergoing a cesarean section using the FAUCS technique

    Procedure: French Abulatory Cesrean Section

  • Active comparator
    Control

    Patients undergoing a cesarean section using the traditional (Misgav-Ladach) technique

    Procedure: Misgav-Ladach

Interventions

  • ProcedureFrench Abulatory Cesrean Section

    A cesarean section performed according to the FAUCS technique

  • ProcedureMisgav-Ladach

    A cesarean section performed according to the Misgav Ladach technique

06

What researchers measure

Primary outcomes

  1. Composite maternal adverse outcome

    The rate of women with a composite maternal adverse outcome, defined as at least one of the following: Visual Analogue Scale score \>6 (scale of 1-10, 1 being a very mild pain, 10 being the worst pain imagineable) at 3-4 hours post surgery, inability to ambulate 3-4 hours post surgery, and QoR15 (Quality of Recovery) score \< 90 (range 0 to 150, 150 being the best recovery after surgery) at 24 hours post surgery

    Time frame: 24 hours post surgery

Secondary outcomes

  1. Length of surgery

    The duration of surgery (in minutes) from incision until closure.

    Time frame: 24 hours

  2. Blood loss (ml) during surgery

    The estimated volume of blood (in ml) lost during surgery

    Time frame: 24 hours

  3. Birthweight

    The weight (grams) of the neonate immediately after birth

    Time frame: immediately after birth

  4. Cord pH

    The pH measured in a blood sample from the umbilical artery

    Time frame: immediately after birth

  5. Birth trauma

    The rate of birthtrauma in diagnosed in the neonate (shoulder dystocia, fracture, cerebral hemorrhage, cephalhematoma, etc.)

    Time frame: 24 hours

07

Study locations

1 of 1 sites recruiting
  • Bnai-Zion Medical Center
    Haifa, Israel
    • Rami Sammour · Contact · 0506267390
    • Shlomi Sagie, MD · Principal investigator
    • Rami Sammour, MD · Sub investigator
    • Israel Hendler, MD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03812406
Lead sponsor
Bnai Zion Medical Center
Responsible party
Sponsor
First posted
Jan 23, 2019
Start date
Aug 19, 2018
Primary completion
Aug 19, 2019 (estimated)
Completion
Sep 19, 2019 (estimated)
Last update
Jan 23, 2019

Study contacts

Rami Sammour, MD
Contact
rsammour2002@gmail.com
+972506267390

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion